HEPARIN
Hemodilution
University Hospital FreiburgmixturePhase 3Dormant
B
59/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 44/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Hemodilution cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Acetylsalicylic Acid University Hospital Freiburg | Phase 3 | B |
Acetazolamide University Hospital Freiburg | Phase 3 | B |
Same molecule, other indications
HEPARIN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →